Literature DB >> 11716515

Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.

J S Yakisich1, A Sidén, P Eneroth, M Cruz.   

Abstract

The drug disulfiram is a thiol-reacting drug that is relatively nontoxic when used alone and has been used in the therapy of alcohol abuse for more than 40 years. Several effects of this drug have been reported for DNA synthesis and cell proliferation. In this study, the inhibitory effect of disulfiram on topoisomerase I and II activity was investigated by measuring the relaxation of superhelical plasmid pBR322 DNA. Disulfiram (1-100 microM) inhibited topoisomerase I and II in a concentration-dependent manner (IC(50) congruent with 42 +/- 8 and 30 +/- 9 microM, respectively). Consistent with the assumption that a thiol residue is involved, dithiothreitol (1 mM) markedly prevented the inhibitory effect of disulfiram on the activity of both classes of topoisomerases. These findings might explain certain aspects of disulfiram toxicity and encourage new studies to determine the usefulness of this drug and its analogues as antineoplastic agent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716515     DOI: 10.1006/bbrc.2001.6027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Effects of disulfiram on excitation-contraction coupling in rat soleus muscle.

Authors:  Wissam H Joumaa; Aicha Bouhlel; Claude Léoty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-25       Impact factor: 3.000

2.  Pyruvate decarboxylase provides growing pollen tubes with a competitive advantage in petunia.

Authors:  Nathalie Gass; Tatiana Glagotskaia; Stefan Mellema; Jeroen Stuurman; Mario Barone; Therese Mandel; Ute Roessner-Tunali; Cris Kuhlemeier
Journal:  Plant Cell       Date:  2005-07-01       Impact factor: 11.277

3.  An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells.

Authors:  Wenge Zhu; Chrissie Y Lee; Ronald L Johnson; Jennifer Wichterman; Ruili Huang; Melvin L DePamphilis
Journal:  Mol Cancer Res       Date:  2011-01-21       Impact factor: 5.852

4.  Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth.

Authors:  Jianqing Lin; Michael C Haffner; Yonggang Zhang; Byron H Lee; W Nathaniel Brennen; Justin Britton; Sushant K Kachhap; Joong Sup Shim; Jun O Liu; William G Nelson; Srinivasan Yegnasubramanian; Michael A Carducci
Journal:  Prostate       Date:  2010-08-31       Impact factor: 4.104

5.  Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer.

Authors:  M T Schweizer; J Lin; A Blackford; A Bardia; S King; A J Armstrong; M A Rudek; S Yegnasubramanian; M A Carducci
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-08-20       Impact factor: 5.554

6.  Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts.

Authors:  Hanumantha Rao Madala; Surendra R Punganuru; Francis Ali-Osman; Ruiwen Zhang; Kalkunte S Srivenugopal
Journal:  Oncotarget       Date:  2017-12-15

7.  ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells.

Authors:  Jan S Moreb; Henry V Baker; Lung-Ji Chang; Maria Amaya; M Cecilia Lopez; Blanca Ostmark; Wayne Chou
Journal:  Mol Cancer       Date:  2008-11-24       Impact factor: 27.401

8.  Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells.

Authors:  Kirsi Ketola; Olli Kallioniemi; Kristiina Iljin
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

Review 9.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04

10.  Cell cycle specific radiosensitisation by the disulfiram and copper complex.

Authors:  Mathias Tesson; Giorgio Anselmi; Caitlin Bell; Robert Mairs
Journal:  Oncotarget       Date:  2017-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.